Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

NCT00729586 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

NIH

Sponsor class

Conditions

Endometrial Carcinoma
Recurrent Uterine Corpus Carcinoma
Stage IIIA Uterine Corpus Cancer
Stage IIIB Uterine Corpus Cancer
Stage IIIC1 Uterine Corpus Cancer
Stage IIIC2 Uterine Corpus Cancer
Stage IVA Uterine Corpus Cancer
Stage IVB Uterine Corpus Cancer

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Megestrol Acetate
DRUG: Tamoxifen Citrate
DRUG: Temsirolimus

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]